Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-04-04

Clinical Trial Update: Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100

View source ↗

Summary

This update reports biomarker analyses from tumor samples to study DNA changes and their relation to treatment response in breast cancer patients treated with b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Breast Cancer | Status: COMPLETED